Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer
Status:
Terminated
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This randomized phase III trial studies calcium and magnesium to see how well they work in
preventing peripheral neuropathy caused by ixabepilone in patients with breast cancer. Giving
calcium together with magnesium may stop or delay the development of peripheral neuropathy in
patients with cancer who are receiving treatment with ixabepilone. It is not yet known
whether calcium and magnesium are effective in preventing peripheral neuropathy caused by
ixabepilone.